p27kip1 is a cyclin-dependent kinase inhibitor that regulates progression from G1 into S phase. Aberrations in cell cycle control are often observed in tumors d might even be necessary in tumor development. Recent reports showed that low 7kip1 expression is associated with poor prognosis in several tumors and ukemia. To investigate the expression of p27kip1 in malignant lymphomas and ucidate the role of p27kip1 as a possible prognostic indicator, the authors rformed an immunohistochemical staining of p27kip1 correlated with Ki-67 belling index and clinical parameters. p27kip1 expression was reduced variably most malignant lymphomas and inversely correlated with Ki-67 labelling index +AD0-0.0151). Regarding chemotherapeutic response, p271kip1 expression in the mplete remission group showed statistically significant difference in pression compared to the progressive disease group (p+AD0-0.0021). There were gnificant differences in survival between cases with low and high p27kip1 pression (p+AD0-0.0071). In a multivariate Cox analysis, p27kip1 expression was dependent prognostic factors as well as other known prognostic factors cluding age, grade, stage and chemotherapeutic response. In conclusion, the udy suggests that reduced expression of p27kip1 protein may play a role in the thogenesis and biologically aggressive behavior of malignant lymphomas.
Adolescence ; Adult ; Aged ; Antineoplastic Agents, Combined/therapeutic use ; Cell Cycle ; Cell Division ; Child ; Child, Preschool ; Comparative Study ; Female ; Follow-Up Studies ; Human ; Ki-67 Antigen/analysis ; Life Tables ; Lymphoma, Non-Hodgkin/pathology ; Lymphoma, Non-Hodgkin/mortality ; Lymphoma, Non-Hodgkin/drug therapy ; Lymphoma, Non-Hodgkin/chemistry+ACo- ; Male ; Microtubule-Associated Proteins/physiology ; Microtubule-Associated Proteins/analysis+ACo- ; Middle Age ; Neoplasm Proteins/physiology ; Neoplasm Proteins/analysis+ACo- ; Prognosis ; Proportional Hazards Models ; Survival Analysis ; Treatment Outcome

p27kip1 is a cyclin-dependent kinase inhibitor that regulates progression from G1 into S phase. Aberrations in cell cycle control are often observed in tumors d might even be necessary in tumor development. Recent reports showed that low 7kip1 expression is associated with poor prognosis in several tumors and ukemia. To investigate the expression of p27kip1 in malignant lymphomas and ucidate the role of p27kip1 as a possible prognostic indicator, the authors rformed an immunohistochemical staining of p27kip1 correlated with Ki-67 belling index and clinical parameters. p27kip1 expression was reduced variably most malignant lymphomas and inversely correlated with Ki-67 labelling index +AD0-0.0151). Regarding chemotherapeutic response, p271kip1 expression in the mplete remission group showed statistically significant difference in pression compared to the progressive disease group (p+AD0-0.0021). There were gnificant differences in survival between cases with low and high p27kip1 pression (p+AD0-0.0071). In a multivariate Cox analysis, p27kip1 expression was dependent prognostic factors as well as other known prognostic factors cluding age, grade, stage and chemotherapeutic response. In conclusion, the udy suggests that reduced expression of p27kip1 protein may play a role in the thogenesis and biologically aggressive behavior of malignant lymphomas.
Adolescence ; Adult ; Aged ; Antineoplastic Agents, Combined/therapeutic use ; Cell Cycle ; Cell Division ; Child ; Child, Preschool ; Comparative Study ; Female ; Follow-Up Studies ; Human ; Ki-67 Antigen/analysis ; Life Tables ; Lymphoma, Non-Hodgkin/pathology ; Lymphoma, Non-Hodgkin/mortality ; Lymphoma, Non-Hodgkin/drug therapy ; Lymphoma, Non-Hodgkin/chemistry+ACo- ; Male ; Microtubule-Associated Proteins/physiology ; Microtubule-Associated Proteins/analysis+ACo- ; Middle Age ; Neoplasm Proteins/physiology ; Neoplasm Proteins/analysis+ACo- ; Prognosis ; Proportional Hazards Models ; Survival Analysis ; Treatment Outcome